TrialJournal of neuro-oncology2018
Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma.
J Duerinck et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this paperpooled ittrialcites it